Lista de obras - Alexey Ushmorov - Dominio Público Uruguay

ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma

artículo científico publicado en 2008

Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combination with small molecular weight inhibitors

artículo científico publicado en 2016

Decitabine represses translocated MYC oncogene in Burkitt lymphoma.

artículo científico publicado en 2013

Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia

artículo científico publicado en 1999

Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.

artículo científico publicado en 2005

Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice.

artículo científico publicado en 1994

Enriching suicide gene bearing tumor cells for an increased bystander effect

artículo científico publicado en 2006

Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma

artículo científico publicado en 2005

Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression

artículo científico publicado en 2004

Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors

artículo científico publicado en 2012

FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma

scientific article published on 25 September 2019

FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.

artículo científico publicado en 2014

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.

artículo científico publicado en 2012

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

artículo científico publicado en 2014

Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis.

artículo científico publicado en 2000

Growth inhibition of murine neuroblastoma cells by C-Myc with cell cycle arrest in G2/M

artículo científico publicado en 2005

Growth-stimulating phase of macrophage response to activation: the phenomenon and its implications for tumour growth and immunotherapy

artículo científico publicado en 1992

Inhibition of nitric-oxide-mediated apoptosis in Jurkat leukemia cells despite cytochrome c release

artículo científico publicado en 2001

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.

artículo científico publicado en 2010

Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex

artículo científico publicado en 2000

Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide

artículo científico publicado en 1992

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

artículo científico publicado en 2008

Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).

artículo científico publicado en 2000

Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release

artículo científico publicado en 1999

Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma

scientific article published on 12 November 2019

Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.

artículo científico publicado en 2016

TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway

artículo científico publicado en 2009

Targeting the intratumor heterogeneity in PMBL.

artículo científico publicado en 2014

The granzyme B inhibitor PI-9 is differentially expressed in all main subtypes of pediatric acute lymphoblastic leukemias

artículo científico publicado en 2004

The synthetic peptide related to the central part of human interleukin-2 molecule accelerates growth and vascularization of sarcoma 180 in mice

scientific article published on 01 May 2000

[Angiogenesis as a target for antitumor actions]

scientific article published on 01 January 1989

[Technology of liquid dosing]

artículo científico publicado en 1997

[The effect of a synthetic fragment of human interleukin-2 on the growth and vascularization of sarcoma 180 in mice]

artículo científico publicado en 1991

[The prospects for using nonsteroidal anti-inflammatory agents in the treatment of malignant neoplasms]

artículo científico publicado en 1990

Lista de obras de Alexey Ushmorov

ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma

Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combination with small molecular weight inhibitors

Decitabine represses translocated MYC oncogene in Burkitt lymphoma.

Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia

Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.

Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice.

Enriching suicide gene bearing tumor cells for an increased bystander effect

Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma

Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression

Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors

FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma

FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis.

Growth inhibition of murine neuroblastoma cells by C-Myc with cell cycle arrest in G2/M

Growth-stimulating phase of macrophage response to activation: the phenomenon and its implications for tumour growth and immunotherapy

Inhibition of nitric-oxide-mediated apoptosis in Jurkat leukemia cells despite cytochrome c release

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.

Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex

Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide

N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells

Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).

Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release

Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma

Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.

TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway

Targeting the intratumor heterogeneity in PMBL.

The granzyme B inhibitor PI-9 is differentially expressed in all main subtypes of pediatric acute lymphoblastic leukemias

The synthetic peptide related to the central part of human interleukin-2 molecule accelerates growth and vascularization of sarcoma 180 in mice

[Angiogenesis as a target for antitumor actions]

[Technology of liquid dosing]

[The effect of a synthetic fragment of human interleukin-2 on the growth and vascularization of sarcoma 180 in mice]

[The prospects for using nonsteroidal anti-inflammatory agents in the treatment of malignant neoplasms]